Home Shennon

Shennon

In operation
Seed Round Financing
Immunotherapy Developer

Basic Information

Shenon Biotechnologies (ShenonBio) is a biotechnology company that uses a proprietary single-cell platform to create more effective immunotherapies. The company has developed a proprietary platform capable of functionally analyzing millions of immune cells at the single-cell level within a few hours, enabling the identification of TCR or antibody targets to develop more precise and effective immunotherapies.
Shennon Biotechnologies, Inc.
SanFrancisco,California,United States of America
unclear
January 01, 2021
info@shennonbio.com